[ad_1]
When a 35-year-old woman with stage 4 gastric cancer appeared in a Dubai hospital, the doctor realized that the cancer had actively spread in her abdomen, making it impossible to operate.
This was when they decided to treat her with a new type of advanced chemotherapy called PIPAC, which gave her the “best chance” for what her doctor said to overcome the deadly disease.
PIPAC is a new, minimally invasive method that introduces chemotherapy into the abdomen under pressure through a 1-cm port to treat advanced gastric, colon, and ovarian cancers.
It is a method of chemotherapy in the form of aerosol. The doctor explained that it includes performing laparoscopy and using the pressure gained inside the abdomen to achieve high-concentration chemotherapy without the side effects of systemic chemotherapy.
This is the first time such treatment in the UAE has been carried out at Mediclinic Parkview Hospital in Dubai.
Treatment was carried out by consultant surgeons Dr. Zakir K Mohamed and Professor Amir Nisar and consultant oncologist Dr. Shaheena Dawood. It involves laparoscopy to assess the cancer and the infusion of two different chemotherapy drugs to the cancer under pressure.
Dr. Olivia Sgarbura, an oncological surgeon from the Montpellier Regional Cancer Institute in France, flew to Dubai to help the team perform the first operation.
When talking about the advantages of this treatment, Dr. Zakir Mohamed, general counsel and colorectal surgeon at Mediclinic Parkview Hospital, said: “Young advanced cancer patients are at a disadvantage and often have to go abroad to seek advanced treatments. Mediclinic aims to provide The most advanced cancer treatment locally. With the introduction of PIPAC, in addition to the recent introduction of robotic surgery, HIPEC treatment and transplant surgery in Mediclinic, the UAE has reaffirmed its position as a regional leader in healthcare and medical tourism.”
Dr. Shaheena Dawood, oncology consultant at Mediclinic City Hospital Comprehensive Cancer Center and Mediclinic Parkview Hospital, said that patients with advanced cancer limited to the abdomen usually cannot receive systemic chemotherapy alone to get a good response.
“Combining the two strategies of systemic chemotherapy with new methods such as PIPAC (allowing chemotherapy to be inserted directly into the abdomen) can enhance the response to treatment. Our ultimate goal is to improve the prognosis of patients and be able to do this; we New strategies need to be adopted and adapted.”
Professor Amir Nisar, a consultant general surgeon at the hospital, explained how this new treatment works: “Chemotherapy (anti-cancer drugs) is usually given by injection, but PIPAC is a type of cancer that directly exposes the cancer in the abdomen to chemotherapy. Innovative methods. Through minimally invasive methods.”
He added: “Recovery is very fast. Studies have shown that this method is beneficial for advanced cancers such as stomach cancer (gastric cancer), bowel cancer (colon cancer), ovarian cancer and other cancers involving abdominal organs.
saman@khaleejtimes.com
Saman Hazik
[ad_2]
Source link